The correlation between the cardio-ankle vascular index (CAVI) and serum amyloid A in asymptomatic Japanese subjects

Heart and Vessels

Volumn 27, Issue 5, 2012, Pages 499-504

  Kotani, Kazuhiko ^a   Yamada, Toshiyuki ^a   Miyamoto, Michiaki ^a   Kario, Kazuomi ^a   Ishibashi, Shun ^a   Taniguchi, Nobuyuki ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Blood pressure; C reactive protein; Chronic inflammation; Pulse wave velocity

Indexed keywords

CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SERUM AMYLOID A; TRIACYLGLYCEROL;

ADULT; ARTERIAL STIFFNESS; ARTICLE; BODY MASS; CARDIO ANKLE VASCULAR INDEX; CARDIOVASCULAR PARAMETERS; CHOLESTEROL BLOOD LEVEL; CHRONIC INFLAMMATION; CIGARETTE SMOKING; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MULTIPLE LINEAR REGRESSION ANALYSIS; PRIORITY JOURNAL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE;

ANKLE BRACHIAL INDEX; ATHEROSCLEROSIS; BLOOD PRESSURE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; REFERENCE VALUES; SERUM AMYLOID A PROTEIN; VASCULAR STIFFNESS;

EID: 84866740542     PISSN: 09108327     EISSN: 16152573     Source Type: Journal    
DOI: 10.1007/s00380-011-0182-9     Document Type: Article

References (40)

1. Levi F, Lucchini F, Negri E, La Vecchia C (2002) Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world. Heart 88:119-124
2. Asmar R, Benetos A, Topouchian J, Laurent P, Pannier B, Brisac AM, Target R, Levy BI (1995) Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension 26:485-490
3. Lehmann ED (1999) Clinical value of aortic pulse-wave velocity measurement. Lancet 354:528-529
4. Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, Schalekamp MA, Asmar R, Reneman RS, Hoeks AP, Breteler MM, Witteman JC (2006) Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation 113:657-663
5. Willum-Hansen T, Staessen JA, Torp-Pedersen C, Rasmussen S, Thijs L, Ibsen H, Jeppesen J (2006) Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 113:664-670
6. Yamashina A, Tomiyama H, Arai T, Koji Y, Yambe M, Motobe H, Glunizia Z, Yamamoto Y, Hori S (2003) Nomogram of the relation of brachial-ankle pulse wave velocity with blood pressure. Hypertens Res 26:801-806
7. Shirai K, Utino J, Otsuka K, Takata M (2006) A novel blood pressure-independent arterial wall stiffness parameter; cardioankle vascular index (CAVI). J Atheroscler Thromb 13:101-107
8. Kotani K, Miyamoto M, Taniguchi N (2010) Clinical significance of the cardio-ankle vascular index (CAVI) in hypertension. Curr Hypertens Rev 6:251-253
9. Shirai K, Hiruta N, Song M, Kurosu T, Suzuki J, Tomaru T, Miyashita Y, Saiki A, Takahashi M, Suzuki K, Takata M (2011) Cardio-ankle vascular index (CAVI) as a novel indicator of arterial stiffness: theory, evidence and perspectives. J Atheroscler Thromb (Epub ahead of print)
10. Kadota K, Takamura N, Aoyagi K, Yamasaki H, Usa T, Nakazato M, Maeda T, Wada M, Nakashima K, Abe K, Takeshima F, Ozono Y (2008) Availability of cardio-ankle vascular index (CAVI) as a screening tool for atherosclerosis. Circ J 72:304-308
11. Miyoshi T, Doi M, Hirohata S, Kamikawa S, Usui S, Ogawa H, Sakane K, Izumi R, Ninomiya Y, Kusachi S (2010) Olmesartan reduces arterial stiffness and serum adipocyte fatty acid-binding protein in hypertensive patients. Heart Vessels 26:408-413
12. Mineoka Y, Fukui M, Tanaka M, Tomiyasu KI, Akabame S, Nakano K, Yamazaki M, Hasegawa G, Oda Y, Nakamura N (2011) Relationship between cardio-ankle vascular index (CAVI) and coronary artery calcification (CAC) in patients with type 2 diabetes mellitus. Heart Vessels (Epub ahead of print)
13. Libby P, Ridker PM, Hansson GK (2009) Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 54:2129-2138
14. Libby P, Ridker PM, Libby P, Ridker PM (2004) Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. Am J Med 116:S9-S16
15. de Ferranti SD, Rifai N (2007) C-reactive protein: a nontraditional serum marker of cardiovascular risk. Cardiovasc Pathol 16:14-21
16. Yamada T (1999) Serum amyloid A (SAA): a concise review of biology, assay methods and clinical usefulness. Clin Chem Lab Med 37:381-388
17. Morrow DA, Rifai N, Antman EM, Weiner DL, McCabe CH, Cannon CP, Braunwald E (2000) Serum amyloid A predicts early mortality in acute coronary syndromes: a TIMI 11A substudy. J Am Coll Cardiol 35:358-362
18. Delanghe JR, Langlois MR, De Bacquer D, Mak R, Capel P, Van Renterghem L, De Backer G (2002) Discriminative value of serum amyloid A and other acute-phase proteins for coronary heart disease. Atherosclerosis 160:471-476
19. Johnson BD, Kip KE, Marroquin OC, Ridker PM, Kelsey SF, Shaw LJ, Pepine CJ, Sharaf B, Bairey Merz CN, Sopko G, Olson MB, Reis SE, National Heart, Lung, and Blood Institute (2004) Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 109:726-732
20. Unlü Y, Karapolat S, Karaca Y, Kiziltunç A (2006) Comparison of levels of inflammatory markers and hemostatic factors in the patients with and without peripheral arterial disease. Thromb Res 117:357-364
21. Schillinger M, Exner M, Mlekusch W, Sabeti S, Amighi J, Nikowitsch R, Timmel E, Kickinger B, Minar C, Pones M, Lalouschek W, Rumpold H, Maurer G, Wagner O, Minar E (2005) Inflammation and Carotid Artery-Risk for Atherosclerosis Study (ICARAS). Circulation 111:2203-2209
22. Buyukhatipoglu H, Tiryaki O, Tahta K, Usalan C (2007) Inflammation as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis in haemodialysis patients: the role of chlamydia and cytomegalovirus infection. Nephrology 12:25-32
23. Wohlin M, Helmersson J, Sundström J, Arnlöv J, Vessby B, Larsson A, Andrén B, Lind L, Basu S (2007) Both cyclooxygenase-and cytokine-mediated inflammation are associated with carotid intima-media thickness. Cytokine 38:130-136
24. Uurtuya S, Kotani K, Koibuchi H, Taniguchi N, Yamada T (2009) Serum amyloid A protein and carotid intima-media thickness in healthy young subjects. J Atheroscler Thromb 16:299-300
25. Jylhävä J, Haarala A, Eklund C, Pertovaara M, Kähönen M, Hutri-Kähönen N, Levula M, Lehtimäki T, Huupponen R, Jula A, Juonala M, Viikari J, Raitakari O, Hurme M (2009) Serum amyloid A is independently associated with metabolic risk factors but not with early atherosclerosis: the Cardiovascular Risk in Young Finns Study. J Intern Med 266:286-295
26. Karadag O, Calguneri M, Atalar E, Yavuz B, Akdogan A, Kalyoncu U, Bilgen SA, Ozer N, Ertenli AI, Ovunc K, Kiraz S (2007) Novel cardiovascular risk factors and cardiac event predictors in female inactive systemic lupus erythematosus patients. Clin Rheumatol 26:695-699
27. Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448-454
28. Mattace-Raso FU, van der Cammen TJ, van der Meer IM, Schalekamp MA, Asmar R, Hofman A, Witteman JC (2004) C-reactive protein and arterial stiffness in older adults: the Rotterdam Study. Atherosclerosis 176:111-116
29. Kullo IJ, Seward JB, Bailey KR, Bielak LF, Grossardt BR, Sheedy PF 2nd, Peyser PA, Turner ST (2005) C-reactive protein is related to arterial wave reflection and stiffness in asymptomatic subjects from the community. Am J Hypertens 18:1123-1129
30. Nagano M, Nakamura M, Sato K, Tanaka F, Segawa T, Hiramori K (2005) Association between serum C-reactive protein levels and pulse wave velocity: a population-based cross-sectional study in a general population. Atherosclerosis 180:189-195
31. Pietri P, Vyssoulis G, Vlachopoulos C, Zervoudaki A, Gialernios T, Aznaouridis K, Stefanadis C (2006) Relationship between lowgrade inflammation and arterial stiffness in patients with essential hypertension. J Hypertens 24:2231-2238
32. Wakabayashi I, Masuda H (2006) Association of acute-phase reactants with arterial stiffness in patients with type 2 diabetes mellitus. Clin Chim Acta 365:230-235
33. Wilson PG, Thompson JC, Webb NR, de Beer FC, King VL, Tannock LR (2008) Serum amyloid A, but not C-reactive protein, stimulates vascular proteoglycan synthesis in a pro-atherogenic manner. Am J Pathol 173:1902-1910
34. Furlaneto CJ, Campa A (2000) A novel function of serum amyloid A: a potent stimulus for the release of tumor necrosis factor-alpha, interleukin-1beta, and interleukin-8 by human blood neutrophil. Biochem Biophys Res Commun 268:405-408
35. Hatanaka E, Monteagudo PT, Marrocos MS, Campa A (2007) Interaction between serum amyloid A and leukocytes-a possible role in the progression of vascular complications in diabetes. Immunol Lett 108:160-166
36. Song C, Shen Y, Yamen E, Hsu K, Yan W, Witting PK, Geczy CL, Freedman SB (2009) Serum amyloid A may potentiate prothrombotic and proinflammatory events in acute coronary syndromes. Atherosclerosis 202:596-604
37. Yamada T, Kakihara T, Kamishima T, Fukuda T, Kawai T (1996) Both acute phase and constitutive serum amyloid A are present in atherosclerotic lesions. Pathol Int 46:797-800
38. Meek RL, Urieli-Shoval S, Benditt EP (1994) Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function. Proc Natl Acad Sci USA 91:3186-3190
39. O'Brien KD, McDonald TO, Kunjathoor V, Eng K, Knopp EA, Lewis K, Lopez R, Kirk EA, Chait A, Wight TN, deBeer FC, LeBoeuf RC (2005) Serum amyloid A and lipoprotein retention in murine models of atherosclerosis. Arterioscler Thromb Vasc Biol 25:785-790
40. van Lenten BJ, Hama SY, de Beer FC, Stafforini DM, McIntyre TM, Prescott SM, La Du BN, Fogelman AM, Navab M (1995) Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest 96:2758-2767